| Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, CE Green, AM Perez, ... American Journal of Psychiatry 170 (10), 1134-1142, 2013 | 1393 | 2013 |
| Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder DA Pizzagalli, AJ Holmes, DG Dillon, EL Goetz, JL Birk, R Bogdan, ... American Journal of Psychiatry 166 (6), 702-710, 2009 | 1380 | 2009 |
| Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task DA Pizzagalli, D Iosifescu, LA Hallett, KG Ratner, M Fava Journal of psychiatric research 43 (1), 76-87, 2008 | 940 | 2008 |
| Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression JW Murrough, AM Perez, S Pillemer, J Stern, MK Parides, M aan het Rot, ... Biological psychiatry 74 (4), 250-256, 2013 | 822 | 2013 |
| Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial A Feder, MK Parides, JW Murrough, AM Perez, JE Morgan, S Saxena, ... JAMA psychiatry 71 (6), 681-688, 2014 | 612 | 2014 |
| A randomized controlled trial of intranasal ketamine in major depressive disorder KAB Lapidus, CF Levitch, AM Perez, JW Brallier, MK Parides, L Soleimani, ... Biological psychiatry 76 (12), 970-976, 2014 | 565 | 2014 |
| Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation RS McIntyre, JD Rosenblat, CB Nemeroff, G Sanacora, JW Murrough, ... American Journal of Psychiatry 178 (5), 383-399, 2021 | 526 | 2021 |
| Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies JW Murrough, B Iacoviello, A Neumeister, DS Charney, DV Iosifescu Neurobiology of learning and memory 96 (4), 553-563, 2011 | 416 | 2011 |
| Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ... Molecular psychiatry 25 (7), 1592-1603, 2020 | 414 | 2020 |
| Pharmacotherapy of anxiety disorders: current and emerging treatment options A Garakani, JW Murrough, RC Freire, RP Thom, K Larkin, FD Buono, ... Frontiers in psychiatry 11, 595584, 2020 | 411 | 2020 |
| Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment‐resistant depression RB Price, DV Iosifescu, JW Murrough, LC Chang, RK Al Jurdi, SZ Iqbal, ... Depression and anxiety 31 (4), 335-343, 2014 | 384 | 2014 |
| A digital brain atlas for surgical planning, model-driven segmentation, and teaching R Kikinis, ME Shenton, DV Iosifescu, RW McCarley, P Saiviroonporn, ... IEEE Transactions on visualization and computer graphics 2 (3), 232-241, 1996 | 383 | 1996 |
| Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression MT Treadway, ML Waskom, DG Dillon, AJ Holmes, MTM Park, ... Biological psychiatry 77 (3), 285-294, 2015 | 366 | 2015 |
| Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial JW Murrough, L Soleimani, KE DeWilde, KA Collins, KA Lapidus, ... Psychological medicine 45 (16), 3571-3580, 2015 | 344 | 2015 |
| QT interval and antidepressant use: a cross sectional study of electronic health records VM Castro, CC Clements, SN Murphy, VS Gainer, M Fava, JB Weilburg, ... Bmj 346, f288, 2013 | 344 | 2013 |
| A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment M Fava, LM Graves, F Benazzi, MJ Scalia, DV Iosifescu, JE Alpert, ... Journal of Clinical Psychiatry 67 (11), 1754-1759, 2006 | 291 | 2006 |
| Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression CN Haile, JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, A Foulkes, ... International Journal of Neuropsychopharmacology 17 (2), 331-336, 2014 | 287 | 2014 |
| Ketamine treatment and global brain connectivity in major depression CG Abdallah, LA Averill, KA Collins, P Geha, J Schwartz, C Averill, ... Neuropsychopharmacology 42 (6), 1210-1219, 2017 | 279 | 2017 |
| Ketamine safety and tolerability in clinical trials for treatment-resistant depression LB Wan, CF Levitch, AM Perez, JW Brallier, DV Iosifescu, LC Chang, ... The Journal of clinical psychiatry 76 (3), 10121, 2014 | 249 | 2014 |
| Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model RH Perlis, DV Iosifescu, VM Castro, SN Murphy, VS Gainer, J Minnier, ... Psychological medicine 42 (1), 41-50, 2012 | 223 | 2012 |
